Sunshine Biopharma Inc. says it lowered the price for its Series B Warrants to $1.2046.

Sep 11, 2026, 6:50 PM ETPaperworkRead the original at sec.gov

Neutral

The company cut its Series B warrant price to $1.2046 after ATM sales; this raises cash but also adds dilution, and the exercise price is still far above the current $0.03 share price.

SBFM · Sunshine Biopharma Inc.

AI read · Neutral

The AI's read

Sunshine filed an 8-K saying recent ATM sales cut its Series B warrant exercise price to $1.2046. The cut follows share sales that raise cash but also dilute holders. The warrant price remains far above the stock's $0.03 quote, so the update does not change how I read Sunshine today.

Get alerts for SBFM

Follow Sunshine Biopharma Inc. (SBFM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SBFM

Free on the App Store and Google Play, or on the web.